American Journal of Psychiatry , 171(3), 276293
However, these findings are not outcome claims, and researchers should treat retatrutide as a platform for studying how multiple hormonal inputs converge within complex metabolic systems
Tips voor combineren en maximale besparing Controleer of de webshop toestaat dat je staffelkorting + promotiecode tegelijk gebruikt
Several factors influence the degree of weight regain after discontinuation: Biological factors : Your body's metabolic adaptation during weight loss includes decreased energy expenditure and increased hunger hormones (such as ghrelin), which persist after stopping medication
Tesamorelins growth hormone elevation directly counteracts these adaptive responses
Phase 2 trial results, published in 2023 in the New England Journal of Medicine (Jastreboff et al., NEJM 2023), demonstrated that participants receiving the highest dose of retatrutide lost an average of approximately 24% of their body weight over 48 weeks a finding that attracted considerable attention from the medical and scientific communities